Alliance-N0577: Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma

This study has been developed to treat people with anaplastic or low-grade glioma brain tumors which are positive for (contain) the 1p/19q co-deletion and IDH tumor markers.

Learn more about the Alliance-N0577 trial or call the Protocol Office at 484-628-8193.

Johns Hopkins-J1426: A Randomized Phase II Study of Subventricular Zone (SVZ) IrradiationPlus Temozolomide in Newly Diagnosed Glioblastoma Multiforme

This research is being done to see if an investigational method of giving radiation to adults with glioblastoma multiforme (GBM) can improve the local control and increase the time it may take to keep your brain cancer from coming back.

Learn more about the Johns Hopkins-J1426 trial or call the Protocol Office at 484-628-8193.

TJU-16D.651: Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery: A Phase II Study

This is a study to evaluate the impact of radiosurgery on neurological function, particularly short-term memory.

Learn more about TJU-16D.651 trial or call the Protocol Office at 484-628-8193.